Anti-BLyS/APRIL Antibody (Atacicept)
Catalog No.
F2116
Anti-BLyS/APRIL Antibody (Atacicept)
Featured Products
Atacicept is a recombinant fusion protein composed of the Fc portion of human IgG1 and the extracellular domain of the TACI receptor. It inhibits the survival and differentiation of B cells by binding to BLyS (B lymphocyte stimulator) and APRIL (proliferation-inducing ligand), thereby being used to treat autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
Dry ice
845264-92-8
-80℃
2 Years
Liquid
1 mg/mL
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
TACI-Ig, A-623, TACI-Fc 5
100 mM Pro 20 mM Arg pH 5.0.
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
BLyS/APRIL
Please avoid freeze-thaw cycles.